Literature DB >> 33541271

The stress hyperglycaemia ratio is associated with left ventricular remodelling after first acute ST-segment elevation myocardial infarction.

Shuai Meng1, Yong Zhu2, Kesen Liu2, Ruofei Jia1, Jing Nan1, Maolin Chen2, Xuan Lei2, Kaiyuan Zou2, Zening Jin3,4.   

Abstract

BACKGROUND: Left ventricular negative remodelling after ST-segment elevation myocardial infarction (STEMI) is considered as the major cause for the poor prognosis. But the predisposing factors and potential mechanisms of left ventricular negative remodelling after STEMI remain not fully understood. The present research mainly assessed the association between the stress hyperglycaemia ratio (SHR) and left ventricular negative remodelling.
METHODS: We recruited 127 first-time, anterior, and acute STEMI patients in the present study. All enrolled patients were divided into 2 subgroups equally according to the median value of SHR level (1.191). Echocardiography was conducted within 24 h after admission and 6 months post-STEMI to measure left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD), and left ventricular end-systolic diameter (LVESD). Changes in echocardiography parameters (δLVEF, δLVEDD, δLVESD) were calculated as LVEF, LVEDD, and LVESD at 6 months after infarction minus baseline LVEF, LVEDD and LVESD, respectively.
RESULTS: In the present study, the mean SHR was 1.22 ± 0.25 and there was significant difference in SHR between the 2 subgroups (1.05 (0.95, 1.11) vs 1.39 (1.28, 1.50), p < 0.0001). The global LVEF at 6 months post-STEMI was significantly higher in the low SHR group than the high SHR group (59.37 ± 7.33 vs 54.03 ± 9.64, p  = 0.001). Additionally, the global LVEDD (49.84 ± 5.10 vs 51.81 ± 5.60, p  = 0.040) and LVESD (33.27 ± 5.03 vs 35.38 ± 6.05, p  = 0.035) at 6 months after STEMI were lower in the low SHR group. Most importantly, after adjusting through multivariable linear regression analysis, SHR remained associated with δLVEF (beta = -9.825, 95% CI -15.168 to -4.481, p  < 0.0001), δLVEDD (beta = 4.879, 95% CI 1.725 to 8.069, p  = 0.003), and δLVESD (beta = 5.079, 95% CI 1.421 to 8.738, p  = 0.007).
CONCLUSIONS: In the present research, we demonstrated for the first time that SHR is significantly correlated with left ventricular negative remodelling after STEMI.

Entities:  

Keywords:  Left ventricular ejection fraction; Left ventricular end-diastolic diameter; Left ventricular end-systolic diameter; Left ventricular negative remodelling; ST-segment elevation myocardial infarction; Stress hyperglycaemia ratiol

Year:  2021        PMID: 33541271      PMCID: PMC7863236          DOI: 10.1186/s12872-021-01889-8

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  23 in total

1.  Through the eyes of the A1C: a call to re-examine stress hyperglycemia.

Authors:  Susan S Braithwaite
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

2.  Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio.

Authors:  Gregory W Roberts; Stephen J Quinn; Nyoli Valentine; Tariq Alhawassi; Hazel O'Dea; Stephen N Stranks; Morton G Burt; Matthew P Doogue
Journal:  J Clin Endocrinol Metab       Date:  2015-10-20       Impact factor: 5.958

3.  Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke.

Authors:  Chih-Jen Yang; Wen-I Liao; Jen-Chun Wang; Chia-Lin Tsai; Jiunn-Tay Lee; Giia-Sheun Peng; Chien-Hsing Lee; Chin-Wang Hsu; Shih-Hung Tsai
Journal:  Am J Emerg Med       Date:  2017-03-22       Impact factor: 2.469

4.  The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention.

Authors:  Yeoree Yang; Tae-Hoon Kim; Kun-Ho Yoon; Wook Sung Chung; Youngkeun Ahn; Myung-Ho Jeong; Ki-Bae Seung; Seung-Hwan Lee; Kiyuk Chang
Journal:  Int J Cardiol       Date:  2017-02-22       Impact factor: 4.164

5.  Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients.

Authors:  Christophe Bauters; Pierre V Ennezat; Olivier Tricot; Bénédicte Lauwerier; Robert Lallemant; Hassan Saadouni; Philippe Quandalle; Olivier Jaboureck; Nicolas Lamblin; Thierry Le Tourneau
Journal:  Eur Heart J       Date:  2007-02-21       Impact factor: 29.983

6.  Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction.

Authors:  Masaharu Ishihara; Ichiro Inoue; Takuji Kawagoe; Yuji Shimatani; Satoshi Kurisu; Kenji Nishioka; Takashi Umemura; Shuji Nakamura; Masashi Yoshida
Journal:  Am Heart J       Date:  2003-10       Impact factor: 4.749

Review 7.  Critical Care Management of Stress-Induced Hyperglycemia.

Authors:  Ilse Vanhorebeek; Jan Gunst; Greet Van den Berghe
Journal:  Curr Diab Rep       Date:  2018-02-26       Impact factor: 4.810

8.  MicroRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1.

Authors:  Xidong Li; Shouwen Zhang; Mingguang Wa; Zhonghua Liu; Shunpeng Hu
Journal:  J Am Heart Assoc       Date:  2019-11-26       Impact factor: 5.501

9.  Translating the A1C assay into estimated average glucose values.

Authors:  David M Nathan; Judith Kuenen; Rikke Borg; Hui Zheng; David Schoenfeld; Robert J Heine
Journal:  Diabetes Care       Date:  2008-06-07       Impact factor: 19.112

Review 10.  Glucagon orchestrates stress-induced hyperglycaemia.

Authors:  J B Harp; G D Yancopoulos; J Gromada
Journal:  Diabetes Obes Metab       Date:  2016-05-04       Impact factor: 6.577

View more
  2 in total

Review 1.  Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction.

Authors:  Michele Correale; Pietro Mazzeo; Lucia Tricarico; Francesca Croella; Martino Fortunato; Michele Magnesa; Marco Amatruda; Simona Alfieri; Salvatore Ferrara; Vincenzo Ceci; Giuseppe Dattilo; Marco Mele; Massimo Iacoviello; Natale Daniele Brunetti
Journal:  Clin Drug Investig       Date:  2022-06-20       Impact factor: 2.859

2.  WHAT IS STRESS HYPERGLYCEMIA? A SUGGESTION FOR AN IMPROVEMENT OF ITS DEFINITION.

Authors:  G Koraćević; M Zdravković
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.